Literature DB >> 18542740

Adjuvant radiotherapy following radical prostatectomy: Genito-Urinary Radiation Oncologists of Canada Consensus Statement.

Tom Pickles, Scott Morgan, Gerard Morton, Louis Souhami, Padraig Warde, Himu Lukka.   

Abstract

Until the results of 3 randomized trials became known in 2005, the role of adjuvant postoperative radiation therapy following radical prostatectomy was poorly defined. After the publication of these trials, the Genito-Urinary Radiation Oncologists of Canada (GUROC) met and crafted a consensus statement regarding the current place of adjuvant radiation therapy. GUROC also identified gaps in current knowledge and strongly supports ongoing study protocols to further quantify the benefit of postoperative radiotherapy.This report summarizes the main trial findings and the commentary provided during the consensus-building process. It also outlines the subsequent consensus statement.

Year:  2008        PMID: 18542740      PMCID: PMC2422905          DOI: 10.5489/cuaj.467

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  17 in total

1.  Radical prostatectomy versus watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Mirja Ruutu; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Christer Busch; Stig Nordling; Hans Garmo; Juni Palmgren; Hans-Olov Adami; Bo Johan Norlén; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

2.  25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.

Authors:  Christopher R Porter; Koichi Kodama; Robert P Gibbons; Roy Correa; Felix K-H Chun; Paul Perrotte; Pierre I Karakiewicz
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

3.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Laurence Collette; Paul van Cangh; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Jean-Marie Maréchal; Pierre Scalliet; Karin Haustermans; Marianne Piérart
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

Review 4.  Controversies in prostate cancer radiotherapy: consensus development.

Authors:  H Lukka; P Warde; T Pickles; G Morton; M Brundage; L Souhami
Journal:  Can J Urol       Date:  2001-08       Impact factor: 1.344

5.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

6.  The effect of hospital volume on cancer control after radical prostatectomy.

Authors:  L M Ellison; B J Trock; N R Poe; A W Partin
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

7.  An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.

Authors:  Misop Han; Alan W Partin; David Y Chan; Patrick C Walsh
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

8.  International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.

Authors:  Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard Bochner; Hartwig Huland; Peter G Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo H van der Kwast; Peter T Scardino; Michael W Kattan
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

9.  Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose.

Authors:  R K Valicenti; L G Gomella; M Ismail; S G Mulholland; S Strup; R O Petersen; B W Corn; J D Lu
Journal:  Urology       Date:  1998-12       Impact factor: 2.649

10.  Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years.

Authors:  Manfred P Wirth; William A See; David G McLeod; Peter Iversen; Tom Morris; Kevin Carroll
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

View more
  5 in total

1.  Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

Authors:  Michael Sia; Tom Pickles; Gerard Morton; Louis Souhami; Himu Lukka; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

2.  Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further.

Authors:  Paolo Borghetti; Luigi Spiazzi; Claudia Cozzaglio; Sara Pedretti; Bruno Caraffini; Luca Triggiani; Diana Greco; Lilia Bardoscia; Fernando Barbera; Michela Buglione; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2017-09-18       Impact factor: 3.469

3.  Assessing guideline impact on referral patterns of post-prostatectomy patients to radiation oncologists.

Authors:  Amandeep Taggar; Majed Alghamdi; Derek Tilly; Xanthoula Kostaras; Marc Kerba; Siraj Husain; Geoff Gotto; Michael Sia
Journal:  Can Urol Assoc J       Date:  2016 Sep-Oct       Impact factor: 1.862

4.  The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia.

Authors:  Scott Tyldesley; Michael Peacock; James W Morris; Alan So; Charmaine Kim-Sing; Jill Quirt; Michael Carter; Tom Pickles
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

Review 5.  Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life.

Authors:  Hamid Raziee; Alejandro Berlin
Journal:  Front Oncol       Date:  2016-03-24       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.